Hepion Pharmaceuticals annual capital expenditures (capex)
2014
2015
2016
2017
2019
2020
2021
2022
2023
Hepion Pharmaceuticals Capital Expenditures (CapEx) Growth & History (HEPA)
Hepion Pharmaceuticals's capital expenditures (capex) was $14,304 for fiscal 2023.
View full Hepion Pharmaceuticals company overviewHepion Pharmaceuticals annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | $14,304 | −$2,032 | −12.44% |
| 2022 | 2022-12-31 | $16,336 | −$114,069 | −87.47% |
| 2021 | 2021-12-31 | $130,405 | $42,422 | +48.22% |
| 2020 | 2020-12-31 | $87,983 | $36,514 | +70.94% |
| 2019 | 2019-12-31 | $51,469 | — | — |
| 2017 · Jun 30 | 2017-06-30 | $14,709 | $8,106 | +122.76% |
| 2016 | 2016-06-30 | $6,603 | −$76,666 | −92.07% |
| 2015 | 2015-06-30 | $83,269 | $67,422 | +425.46% |
| 2014 | 2014-06-30 | $15,847 | — | — |
Hepion Pharmaceuticals quarterly capital expenditures (capex)
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q3.17
Q1.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q4 2023 | 2023-12-31 | $348 | −$15,988 | −97.87% |
| Q3 2023 | 2023-09-30 | $2,582 | $2,582 | — |
| Q2 2023 | 2023-06-30 | $16,538 | $16,538 | — |
| Q1 2023 | 2023-03-31 | $0 | $0 | — |
| Q4 2022 | 2022-12-31 | $16,336 | $16,335 | +1633500.00% |
| Q3 2022 | 2022-09-30 | $0 | −$36,486 | — |
| Q2 2022 | 2022-06-30 | $0 | −$11,815 | — |
| Q1 2022 | 2022-03-31 | $0 | −$82,105 | — |
| Q4 2021 | 2021-12-31 | $1 | −$76,545 | −100.00% |
| Q3 2021 | 2021-09-30 | $36,486 | $36,485 | +3648500.00% |
| Q2 2021 | 2021-06-30 | $11,815 | $379 | +3.31% |
| Q1 2021 | 2021-03-31 | $82,105 | $82,105 | — |
| Q4 2020 | 2020-12-31 | $76,546 | $70,413 | +1148.10% |
| Q3 2020 | 2020-09-30 | $1 | −$1 | −50.00% |
| Q2 2020 | 2020-06-30 | $11,436 | $3,951 | +52.79% |
| Q1 2020 | 2020-03-31 | $0 | −$37,849 | — |
| Q4 2019 | 2019-12-31 | $6,133 | — | — |
| Q3 2019 | 2019-09-30 | $2 | — | — |
| Q2 2019 | 2019-06-30 | $7,485 | — | — |
| Q1 2019 | 2019-03-31 | $37,849 | — | — |
| Q1 2018 · Sep 30 | 2017-09-30 | $0 | — | — |
| Q3 2017 | 2017-03-31 | $0 | $0 | — |
| Q4 2016 | 2016-06-30 | $0 | $0 | — |
| Q3 2016 | 2016-03-31 | $0 | −$29,086 | — |
| Q2 2016 | 2015-12-31 | $0 | −$10,388 | — |
| Q1 2016 | 2015-09-30 | $6,603 | −$37,192 | −84.92% |
| Q4 2015 | 2015-06-30 | $0 | — | — |
| Q3 2015 | 2015-03-31 | $29,086 | — | — |
| Q2 2015 | 2014-12-31 | $10,388 | — | — |
| Q1 2015 | 2014-09-30 | $43,795 | — | — |
Hepion Pharmaceuticals capital expenditures (capex) trends
Between the periods ended 2014-06-30 and 2023-12-31, Hepion Pharmaceuticals's capital expenditures (capex) decreased from $15,847 to $14,304, a change of −$1,543. The latest reported quarter, Q4 2023, shows $348.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Hepion Pharmaceuticals source filings ↗